{"id":877789,"date":"2025-08-21T07:04:11","date_gmt":"2025-08-21T11:04:11","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/vyome-signs-mou-with-embryyo-indias-leading-medical-device-innovation-studio\/"},"modified":"2025-08-21T07:04:11","modified_gmt":"2025-08-21T11:04:11","slug":"vyome-signs-mou-with-embryyo-indias-leading-medical-device-innovation-studio","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/vyome-signs-mou-with-embryyo-indias-leading-medical-device-innovation-studio\/","title":{"rendered":"Vyome Signs MoU with Embryyo, India\u2019s Leading Medical Device Innovation Studio"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Vyome Signs MoU with Embryyo, India\u2019s Leading Medical Device Innovation Studio<\/b><\/p>\n<p class=\"bwalignc\"><b><i>Vyome seeks to access multi-billion-dollar AI-enabled medical device market<\/i><\/b><\/p>\n<p>CAMBRIDGE, Mass. &amp; PUNE, India&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nVyome Holdings, Inc. (Nasdaq: HIND), a clinical-stage healthcare holding company, and Embryyo Technologies today announced the signing of an MoU (Memorandum of Understanding) to jointly pursue the global AI-enabled medical device market. This partnership will combine Vyome&#8217;s healthcare industry experience and resources with Embryyo&#8217;s medical technology capabilities to potentially productize and commercialize smart medical devices that can transform the standard-of-care in disease management and treatment.<\/p>\n<p>\n&#8220;Vyome&#8217;s vision is to partner with the smartest talent tackling the biggest healthcare markets along the US-India corridor and across our three pillars of pharma, AI, and medical devices. AI-enabled medical devices represent a large opportunity and the Embryyo team &#8211; helmed by Indian Institutes of Technology (IIT) alums &#8211; has been working in this sector for a decade. We will be working with them to identify the specific initiatives on which we will partner,&#8221; said Krishna Gupta, Chairman of Vyome Holdings.<\/p>\n<p>\n&#8220;We are excited about this partnership with Vyome as we have a shared vision. We are currently developing a portfolio of transformative medical devices spanning interventional oncology, surgery, wearables, and drug delivery, and Vyome\u2019s access to global capital markets and the U.S. healthcare ecosystem will accelerate our mission to push the frontiers of medicine and elevate standards of care in healthcare globally,\u201d said Nishant Kumar, Co-Founder and CEO of Embryyo Technologies.<\/p>\n<p>\nAs part of this partnership, Vyome and Embryyo will host a global AI-enabled medical device innovation forum for companies along the US-India corridor. The MoU is non-binding and may be subject to other conditions.<\/p>\n<p><b>About Vyome<\/b><\/p>\n<p>\nVyome is building the world\u2019s premier platform spanning the US-India innovation corridor. Based in Cambridge, MA, Vyome\u2019s immediate focus is leveraging its clinical-stage assets to transform the lives of patients with immuno-inflammatory conditions. By applying groundbreaking science and its unique positioning across the US-India innovation corridor, Vyome seeks to deliver lasting value to shareholders in a hyper cost-efficient manner while upholding global standards of quality and safety. To learn more, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.vyometx.com&amp;esheet=54311200&amp;newsitemid=20250821234483&amp;lan=en-US&amp;anchor=www.vyometx.com&amp;index=1&amp;md5=8edd196899e8df4280aac123857e9be2\">www.vyometx.com<\/a>.<\/p>\n<p><b>About Embryyo<\/b><\/p>\n<p>\nEmbryyo is a medical device innovation studio which specializes in unmet clinical need discovery and validation, ideation, IP creation, early-stage technology de-risking and medical device product development. Over the years, Embryyo has worked with a diverse global clientele including med-tech MNC&#8217;s, inventive clinicians, philanthropic institutions, category leading manufacturers and funded startups, helping them identify, invent and realize first-of-its-kind medical devices. The company has also created a strong internal pipeline of early-stage med-tech IP assets which we are now outlicensing and commercialising through global partners and collaborators.<\/p>\n<p><b>Forward-Looking Statements<\/b><\/p>\n<p>\nCertain statements made in this press release are \u201cforward-looking statements\u201d within the meaning of the \u201csafe harbor\u201d provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as \u201ctarget,\u201d \u201cbelieve,\u201d \u201cexpect,\u201d \u201cwill,\u201d \u201cshall,\u201d \u201cmay,\u201d \u201canticipate,\u201d \u201cestimate,\u201d \u201cwould,\u201d \u201cpositioned,\u201d \u201cfuture,\u201d \u201cforecast,\u201d \u201cintend,\u201d \u201cplan,\u201d \u201cproject,\u201d \u201coutlook\u201d, and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Examples of forward-looking statements include, among others, statements made in this release regarding the merger, including the benefits of the merger, revenue opportunities, anticipated future financial and operating performance, and results, including estimates for growth. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on management\u2019s current beliefs, expectations, and assumptions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of Vyome\u2019s control. Actual results and outcomes may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause actual results and outcomes to differ materially from those indicated in the forward-looking statements include, among others, the following: (a) the occurrence of any event, change, or other circumstances relating to the combined company; (b) failure to obtain the necessary consents and approvals; (c) the risk that the merger disrupts current plans and operations as a result of the announcement and consummation of the merger; (e) costs related to the merger; and (f) changes in applicable laws or regulations. Vyome cautions that the foregoing list of factors is not exhaustive. Vyome cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Vyome does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, whether as a result of new information, future events, or otherwise, except as may be required by applicable law.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250821234483r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20250821234483\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20250821234483\/en\/<\/a><\/span><\/p>\n<p><b>Media contact:<br \/>\n<br \/><\/b>ICR for Vyome<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:VyomePR@icrinc.com\">VyomePR@icrinc.com<br \/>\n<\/a><\/p>\n<p>Visit us on social media:<br \/>\n<br \/><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2Fvyometx%2F&amp;esheet=54311200&amp;newsitemid=20250821234483&amp;lan=en-US&amp;anchor=Facebook&amp;index=2&amp;md5=f7272be34583c4560c2d9f76dfd3b748\">Facebook<br \/>\n<\/a><br \/><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fx.com%2FVyomeInc&amp;esheet=54311200&amp;newsitemid=20250821234483&amp;lan=en-US&amp;anchor=X&amp;index=3&amp;md5=8fc3d319b7464ebe88520f3b63269a77\">X<br \/>\n<\/a><br \/><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fvyome-therapeutics%2Fposts%2F%3FfeedView%3Dall&amp;esheet=54311200&amp;newsitemid=20250821234483&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=4&amp;md5=ce07b5348201f542bf757d5f5801a8f3\">LinkedIn<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States India North America Asia Pacific Massachusetts<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Medical Devices Health Technology Health Technology Artificial Intelligence Pharmaceutical<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250821234483\/en\/2555470\/3\/Vyome_logo.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Vyome Signs MoU with Embryyo, India\u2019s Leading Medical Device Innovation Studio Vyome seeks to access multi-billion-dollar AI-enabled medical device market CAMBRIDGE, Mass. &amp; PUNE, India&#8211;(BUSINESS WIRE)&#8211; Vyome Holdings, Inc. (Nasdaq: HIND), a clinical-stage healthcare holding company, and Embryyo Technologies today announced the signing of an MoU (Memorandum of Understanding) to jointly pursue the global AI-enabled medical device market. This partnership will combine Vyome&#8217;s healthcare industry experience and resources with Embryyo&#8217;s medical technology capabilities to potentially productize and commercialize smart medical devices that can transform the standard-of-care in disease management and treatment. &#8220;Vyome&#8217;s vision is to partner with the smartest talent tackling the biggest healthcare markets along the US-India corridor and across our three pillars of pharma, AI, and medical devices. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vyome-signs-mou-with-embryyo-indias-leading-medical-device-innovation-studio\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Vyome Signs MoU with Embryyo, India\u2019s Leading Medical Device Innovation Studio&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-877789","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Vyome Signs MoU with Embryyo, India\u2019s Leading Medical Device Innovation Studio - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vyome-signs-mou-with-embryyo-indias-leading-medical-device-innovation-studio\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vyome Signs MoU with Embryyo, India\u2019s Leading Medical Device Innovation Studio - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Vyome Signs MoU with Embryyo, India\u2019s Leading Medical Device Innovation Studio Vyome seeks to access multi-billion-dollar AI-enabled medical device market CAMBRIDGE, Mass. &amp; PUNE, India&#8211;(BUSINESS WIRE)&#8211; Vyome Holdings, Inc. (Nasdaq: HIND), a clinical-stage healthcare holding company, and Embryyo Technologies today announced the signing of an MoU (Memorandum of Understanding) to jointly pursue the global AI-enabled medical device market. This partnership will combine Vyome&#8217;s healthcare industry experience and resources with Embryyo&#8217;s medical technology capabilities to potentially productize and commercialize smart medical devices that can transform the standard-of-care in disease management and treatment. &#8220;Vyome&#8217;s vision is to partner with the smartest talent tackling the biggest healthcare markets along the US-India corridor and across our three pillars of pharma, AI, and medical devices. &hellip; Continue reading &quot;Vyome Signs MoU with Embryyo, India\u2019s Leading Medical Device Innovation Studio&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/vyome-signs-mou-with-embryyo-indias-leading-medical-device-innovation-studio\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-21T11:04:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250821234483r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vyome-signs-mou-with-embryyo-indias-leading-medical-device-innovation-studio\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vyome-signs-mou-with-embryyo-indias-leading-medical-device-innovation-studio\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Vyome Signs MoU with Embryyo, India\u2019s Leading Medical Device Innovation Studio\",\"datePublished\":\"2025-08-21T11:04:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vyome-signs-mou-with-embryyo-indias-leading-medical-device-innovation-studio\\\/\"},\"wordCount\":883,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vyome-signs-mou-with-embryyo-indias-leading-medical-device-innovation-studio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250821234483r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vyome-signs-mou-with-embryyo-indias-leading-medical-device-innovation-studio\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vyome-signs-mou-with-embryyo-indias-leading-medical-device-innovation-studio\\\/\",\"name\":\"Vyome Signs MoU with Embryyo, India\u2019s Leading Medical Device Innovation Studio - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vyome-signs-mou-with-embryyo-indias-leading-medical-device-innovation-studio\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vyome-signs-mou-with-embryyo-indias-leading-medical-device-innovation-studio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250821234483r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2025-08-21T11:04:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vyome-signs-mou-with-embryyo-indias-leading-medical-device-innovation-studio\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vyome-signs-mou-with-embryyo-indias-leading-medical-device-innovation-studio\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vyome-signs-mou-with-embryyo-indias-leading-medical-device-innovation-studio\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250821234483r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250821234483r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vyome-signs-mou-with-embryyo-indias-leading-medical-device-innovation-studio\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vyome Signs MoU with Embryyo, India\u2019s Leading Medical Device Innovation Studio\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vyome Signs MoU with Embryyo, India\u2019s Leading Medical Device Innovation Studio - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/vyome-signs-mou-with-embryyo-indias-leading-medical-device-innovation-studio\/","og_locale":"en_US","og_type":"article","og_title":"Vyome Signs MoU with Embryyo, India\u2019s Leading Medical Device Innovation Studio - Market Newsdesk","og_description":"Vyome Signs MoU with Embryyo, India\u2019s Leading Medical Device Innovation Studio Vyome seeks to access multi-billion-dollar AI-enabled medical device market CAMBRIDGE, Mass. &amp; PUNE, India&#8211;(BUSINESS WIRE)&#8211; Vyome Holdings, Inc. (Nasdaq: HIND), a clinical-stage healthcare holding company, and Embryyo Technologies today announced the signing of an MoU (Memorandum of Understanding) to jointly pursue the global AI-enabled medical device market. This partnership will combine Vyome&#8217;s healthcare industry experience and resources with Embryyo&#8217;s medical technology capabilities to potentially productize and commercialize smart medical devices that can transform the standard-of-care in disease management and treatment. &#8220;Vyome&#8217;s vision is to partner with the smartest talent tackling the biggest healthcare markets along the US-India corridor and across our three pillars of pharma, AI, and medical devices. &hellip; Continue reading \"Vyome Signs MoU with Embryyo, India\u2019s Leading Medical Device Innovation Studio\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/vyome-signs-mou-with-embryyo-indias-leading-medical-device-innovation-studio\/","og_site_name":"Market Newsdesk","article_published_time":"2025-08-21T11:04:11+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250821234483r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vyome-signs-mou-with-embryyo-indias-leading-medical-device-innovation-studio\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vyome-signs-mou-with-embryyo-indias-leading-medical-device-innovation-studio\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Vyome Signs MoU with Embryyo, India\u2019s Leading Medical Device Innovation Studio","datePublished":"2025-08-21T11:04:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vyome-signs-mou-with-embryyo-indias-leading-medical-device-innovation-studio\/"},"wordCount":883,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vyome-signs-mou-with-embryyo-indias-leading-medical-device-innovation-studio\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250821234483r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vyome-signs-mou-with-embryyo-indias-leading-medical-device-innovation-studio\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/vyome-signs-mou-with-embryyo-indias-leading-medical-device-innovation-studio\/","name":"Vyome Signs MoU with Embryyo, India\u2019s Leading Medical Device Innovation Studio - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vyome-signs-mou-with-embryyo-indias-leading-medical-device-innovation-studio\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vyome-signs-mou-with-embryyo-indias-leading-medical-device-innovation-studio\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250821234483r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2025-08-21T11:04:11+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vyome-signs-mou-with-embryyo-indias-leading-medical-device-innovation-studio\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/vyome-signs-mou-with-embryyo-indias-leading-medical-device-innovation-studio\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vyome-signs-mou-with-embryyo-indias-leading-medical-device-innovation-studio\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250821234483r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250821234483r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vyome-signs-mou-with-embryyo-indias-leading-medical-device-innovation-studio\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Vyome Signs MoU with Embryyo, India\u2019s Leading Medical Device Innovation Studio"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/877789","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=877789"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/877789\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=877789"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=877789"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=877789"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}